Status:
COMPLETED
Randomized Control Trial of Micronized Purified Flavonoid Fraction for Post Operative Treatment in Anal Fistula Surgery
Lead Sponsor:
Taipei Medical University Shuang Ho Hospital
Conditions:
Anal Fistula
Eligibility:
All Genders
20-85 years
Phase:
PHASE4
Brief Summary
The aim of this study is to evaluate the effect of micronized purified flavonoid fraction on postoperative symptoms after surgery of anorectal fistulas.
Detailed Description
The current theory of cryptoglandular suggest that perianal fistula occurs when the anal crypt glands become occluded and infected, over 90% of perianal fistulas are cryptoglandular in origin and aris...
Eligibility Criteria
Inclusion
- Patients who undergo fistulectomy or fistulotomy are included.
Exclusion
- Emergency operation
- Participants who had Trans-sphincteric anal fistula, Extra-sphincteric anal fistula
- Participants accompanied by severe liver cirrhosis
- Participants accompanied by coagulation disorders
- Participants taking anticoagulant
- Participants taking corticosteroids as long-term medication.
- Participants who had colorectal cancer
- Participants taking analgesic drugs (morphine or others) as long-term medication
- Participants bed-ridden
- Participants who had history of human immunodeficiency virus (HIV) infection
- Pregnant woman
Key Trial Info
Start Date :
December 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2025
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT06184438
Start Date
December 13 2023
End Date
March 31 2025
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University Shuang-Ho Hospital
New Taipei City, Taiwan, 235